(Q24242917)

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Randomised trial of corticosteroids in the treatment of tuberculous pleurisy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Corticosteroids in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

The management of pleural space infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Biology of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Tuberculosis and human immunodeficiency virus infection in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Effects of adrenocorticotropic hormone and cortisone in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Glucocorticoids and invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Pleural tuberculosis and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Tuberculous pleural effusion. Twenty-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Identification of risk factors for extrapulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Steroids for treating tuberculous pleurisy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Intrapleural hydrocortisone in tuberculous pleural effusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

STEROID THERAPY IN TUBERCULOUS PLEURAL EFFUSION

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Antituberculous therapy combined with adrenal steroids in the treatment of pleural effusions: a controlled therapeutic trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Steroid-treated tuberculous pleural effusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Tuberculosis of the pleura

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Rifampicin reduces effectiveness and bioavailability of prednisolone.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Using corticosteroids to treat tuberculous pleurisy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Tuberculous pleurisy is more common in AIDS than in non-AIDS patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

TREATMENT OF TUBERCULOUS PLEURAL EFFUSION WITH LOCAL INSTILLATION OF HYDROCORTISONE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021

Clinical and epidemiological features of AIDS/tuberculosis comorbidity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001876.PUB2

7 January 2021